BioSpace News Archive

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired Golden Hour Data Systems, Inc. of San Diego, a privately held company that delivers leading solutions for patient charting and revenue cycle management (RCM) to the EMS market.

At the 15th Annual Conference of the US Human Proteome Organization (www.ushupo.org), Bruker announces further progress in high-sensitivity, high-throughput plasma-proteomics using the timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.

“After working in several nursing environments, I have encountered patients who continue to develop pressure ulcers despite multiple prophylactic methods and continuous skin observation,” said an inventor from DeWitt, Ark. “I wanted to develop an invention that would provide a simple, reusable and inexpensive alternative to current standards of practice to help all healthcare professionals and individuals decrease the incidence of pressure ulcers.”

DispatchHealth, who delivers on-demand healthcare to patients directly in the comfort of their own home, today announced two additional members of its executive team: chief development officer Jennifer Meyer and chief product officer Nabeel Meghji.

Improvements in dialysis care are outpacing outcomes for other chronic disease conditions, improvements that allow patients with End Stage Renal Disease (ESRD) to live longer lives – and yielding substantial savings to Medicare – according to a new fact sheet created from the health care consulting firm Discern Health, which analyzed United States Renal Data System (USRDS) data.

AllianceRx Walgreens Prime is sponsoring accredited, web-based continuing education (CE) customized specifically for members of the National Association of Specialty Pharmacy (NASP), which includes AllianceRx Walgreens Prime pharmacists.

Almirall S.A. (ALM) announced that it has entered into a definitive agreement with Celling Biosciences, based in Austin (Texas), to divest ThermiGen for an undisclosed amount.

Breckenridge Pharmaceutical, Inc. announced that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Imatinib Mesylate Tablets, generic for Gleevec® Tablets by Novartis.

Pharmacy Times Continuing Education™ will host a live CE-accredited webinar on “The Resurgence of Measles in the United States” on Tuesday, March 12, at 8 p.m. (EDT).

LifeSeasons is proud to introduce ReCODE Protocol, a new line of cognitive support supplements formulated with world-renowned neurologist and author of the New York Times bestseller, The End of Alzheimer’s, Dale Bredesen, MD.